---
title: "1 Reason Medtronic (MDT) Is One of the Best Healthcare Stocks You Can Buy Today"
description: "Medtronic (MDT) is currently undervalued despite a high dividend yield of around 3%. The company is enhancing its business performance with new surgical robots and cardiac ablation systems. A planned "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/258320283.md"
published_at: "2025-09-22T09:56:03.000Z"
---

# 1 Reason Medtronic (MDT) Is One of the Best Healthcare Stocks You Can Buy Today

> Medtronic (MDT) is currently undervalued despite a high dividend yield of around 3%. The company is enhancing its business performance with new surgical robots and cardiac ablation systems. A planned spinoff of its diabetes division is expected to boost earnings, as the remaining divisions have higher profit margins. As new products are introduced, Medtronic's earnings growth may exceed Wall Street's expectations, potentially shifting market sentiment from bearish to bullish.

**Medtronic** (MDT -0.68%) is out of favor today, noting it has a historically high dividend yield of around 3%. The company is working on improving its business performance, however, and stronger results are likely on tap. That could make Medtronic one of the best healthcare stocks you can buy today.

## Medtronic was in a funk

As a medical device maker, investing in research and development is a key aspect of Medtronic's business. Only R&D is an inherently lumpy effort, not to mention a time-consuming and expensive one. At least part of the downbeat view around Medtronic today is related to the fact that it went through a development dry spell. That, however, is beginning to change with the company's new surgical robots and cardiac ablation systems starting to gain traction.

Image source: Getty Images.

That, however, is just the start of the investment thesis around Medtronic. It has also been attempting to focus on its most profitable businesses. The next big move on this front will be the spinoff of its diabetes treatment division, which will be immediately accretive to earnings. That's because the rest of the healthcare giant's businesses (in the cardiovascular, medical surgical, and neuroscience niches) have higher profit margins than does the diabetes division.

The big picture here, however, is that as new products come on line, the company's earnings growth could be faster than Wall Street is currently expecting. Higher profit margins, essentially, should help supercharge the increased revenues from R&D developments. All in, you get to collect a high yield today while you wait for investors to catch up to the improving fundamentals of Medtronic's business. When they do catch up, the market could quickly go from being bearish on the stock to being bullish.

### Related Stocks

- [MDT.US - Medtronic](https://longbridge.com/en/quote/MDT.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 美敦力｜8-K：2026 財年 Q3 營收 90.17 億美元超過預期 |  | [Link](https://longbridge.com/en/news/276118790.md) |
| BUZZ-街景：分析師表示，美敦力在早期產品週期中的實力顯而易見 | 美敦力超出了華爾街對第三季度利潤和收入的預期，得益於強勁的心臟設備需求，但維持了全年利潤預測。分析師一致給予 “買入” 評級，目標價中位數為 112.17 美元。Needham 認為美敦力正處於強勁產品週期的早期階段，而 Piper San | [Link](https://longbridge.com/en/news/276231714.md) |
| 美敦力的分析師在第三季度財報發佈後下調了他們的預測 | 美敦力公司（NYSE:MDT）公佈了第三季度財報，調整後每股收益為 1.36 美元，超出預期的 1.33 美元，銷售額為 90.17 億美元，超過預期的 89.05 億美元。該公司重申了 2026 財年的調整後每股收益指導區間為 5.62- | [Link](https://longbridge.com/en/news/276242035.md) |
| Take Solutions 將構建一個用於醫療保健的統一 AI 平台 | Take Solutions Ltd：構建統一的醫療保健人工智能平台 | [Link](https://longbridge.com/en/news/276094006.md) |
| 美敦力在印度啓動 DecodeYourRhythm 活動，旨在提高公眾對心律失常的認識 | 美敦力在印度推出了#DecodeYourRhythm 活動，以提高人們對心動過緩的認識，這是一種以心率緩慢為特徵的疾病。該倡議旨在教育患者、護理人員和醫療專業人士識別早期警示信號並尋求及時的醫療護理。活動中包含一部結合敍事與教育內容的影片， | [Link](https://longbridge.com/en/news/276074775.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
